Advent Plus company information, Employees & Contact Information

Outcomes of patients treated with venetoclax plus azacitidine versus azacitidine alone stratified by advanced age and acute myeloid leukemia composite model Nature

Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial The Lancet

The Guide to the Avis Preferred Loyalty Program NerdWallet

Promising new drugs and therapeutic approaches for treatment of ovarian cancer—targeting the hallmarks of cancer BMC Medicine

Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC) | Blood Cancer Jour Nature

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma The New England Journal of Medicine

6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7) ScienceDirect.com

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial The BMJ

Upcoming Changes for Dually Enrolled Individuals: The Final 2025 Medicare Advantage Rule Justice in Aging

Systemic treatment for advanced pancreatic cancer Baishideng Publishing Group

Cost-effectiveness of first line nivolumab-ipilimumab combination therapy for advanced non-small cell lung cancer: A systematic review and methodological quality assessment Frontiers

Lignin-based nanoencapsulation for sustainable herbicide delivery: controlled release and bioactivity of 2,4-D and MCPA compared to commercial formulations Nature

China Is Rapidly Becoming a Leading Innovator in Advanced Industries Information Technology and Innovation Foundation

Partner Plus IBM

Single-cell multi-omics sequencing uncovers region-specific plasticity of glioblastoma for complementary therapeutic targeting Science | AAAS

Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer The New England Journal of Medicine

Cost-effectiveness analysis of nimotuzumab combined with gemcitabine for K-Ras wild type locally advanced or metastatic pancreatic cancer in China Nature

Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study The Lancet

Novel nomogram for predicting survival in advanced non-small cell lung cancer receiving anti-PD-1 plus chemotherapy with or without antiangiogenic therapy Frontiers

Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial Nature

Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer The New England Journal of Medicine

Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08–2015 ENERGY): a randomised, open-label, phase The Lancet

Pancreatic cancer The Lancet

Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care American Heart Association Journals

Biomolecular sensors for advanced physiological monitoring Nature

Combination Chemo‐Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti‐PD‐1 - Liu - 2021 - Advanced Science Wiley Online Library

The emergence of heat and humidity too severe for human tolerance Science | AAAS

Experience Google Gemini Advanced with No Charge for Six Months on the Samsung Galaxy S25 Series Samsung Global Newsroom

Efficacy and safety of serplulimab plus nab-paclitaxel in previously treated patients with PD-L1–positive advanced cervical cancer: a phase II, single-arm study Frontiers

Klim Badlands Pro A3 ADV Suit Gets Revamped for 2023 ADV Pulse

Targeting HER2-positive breast cancer: advances and future directions Nature

US FDA expands Jemperli (dostarlimab-gxly) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment to show an overall survival benefit Business Wire

Lies Of P: Best Advance Build TheGamer

New and emerging targeted treatments in advanced non-small-cell lung cancer The Lancet

Meta Business Suite facebook.com

2025 Honda X-ADV 750 colour updates for Malaysian, RM69,999 - new DRLs, new TFT screen, DCT update Paul Tan